Cargando…

Unique effects on hepatic function, lipid metabolism, bone and growth endocrine parameters of estetrol in combined oral contraceptives

Objectives Estetrol (E(4)) is a natural estrogen produced by the human fetal liver. In combination with drospirenone (DRSP) or levonorgestrel (LNG), E(4) blocks ovulation and has less effect on haemostatic biomarkers in comparison with ethinylestradiol (EE) combined with DRSP. This study evaluates t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mawet, Marie, Maillard, Catherine, Klipping, Christine, Zimmerman, Yvette, Foidart, Jean-Michel, Coelingh Bennink, Herjan J.T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4699469/ https://www.ncbi.nlm.nih.gov/pubmed/26212489 http://dx.doi.org/10.3109/13625187.2015.1068934

Ejemplares similares

Inhibition of ovulation by administration of estetrol in combination with drospirenone or levonorgestrel: Results of a phase II dose-finding pilot study
por: Duijkers, Ingrid J.M., et al.
Publicado: (2015)

An Oral Contraceptive Containing Estetrol 15 MG and Drospirenone 3 MG Has Limited Effects on Endocrine and Metabolic Parameters
por: Klipping, Christine, et al.
Publicado: (2021)

A multicenter, randomized study to select the minimum effective dose of estetrol (E4) in postmenopausal women (E4Relief): part 1. Vasomotor symptoms and overall safety
por: Gaspard, Ulysse, et al.
Publicado: (2020)

Tumor suppression, dose-limiting toxicity and wellbeing with the fetal estrogen estetrol in patients with advanced breast cancer
por: Schmidt, Marcus, et al.
Publicado: (2020)

A multicenter, randomized, placebo-controlled study to select the minimum effective dose of estetrol in postmenopausal participants (E4Relief): part 2—vaginal cytology, genitourinary syndrome of menopause, and health-related quality of life
por: Gaspard, Ulysse, et al.
Publicado: (2023)

The benefits of estetrol addition to drospirenone for contraception
por: Foidart, Jean Michel, et al.
Publicado: (2023)

Reply to Bexultan Kazybay and Yingqiu Xie’s Letter to the Editor re: Herjan J.T. Coelingh Bennink, Jean-Michel Foidart, Frans M.J. Debruyne. Treatment of Serious COVID-19 with Testosterone Suppression and High-dose Estrogen Therapy. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.06.024
por: Coelingh Bennink, Herjan J.T., et al.
Publicado: (2021)

Treatment of Serious COVID-19 with Testosterone Suppression and High-dose Estrogen Therapy
por: Coelingh Bennink, Herjan J.T., et al.
Publicado: (2021)

The Effect of Estetrol/Drospirenone on Ovarian Function Is Similar to a Well-Established Combined Oral Contraceptive: Results From a Phase 2 Study
por: Duijkers, Ingrid J M, et al.
Publicado: (2021)

Low Thrombin Generation in Users of a Contraceptive Containing Estetrol and Drospirenone
por: Morimont, Laure, et al.
Publicado: (2022)

Estetrol Prevents Hot Flushes and Improves Quality of Life in Patients with Advanced Prostate Cancer Treated with Androgen Deprivation Therapy: The PCombi Study
por: Zimmerman, Yvette, et al.
Publicado: (2022)

Estetrol Combined to Progestogen for Menopause or Contraception Indication Is Neutral on Breast Cancer
por: Gallez, Anne, et al.
Publicado: (2021)

Estetrol and Mammary Gland: Friends or Foes?
por: Gallez, Anne, et al.
Publicado: (2021)

Pro-Apoptotic Effects of Estetrol on Long-Term Estrogen-Deprived Breast Cancer Cells and at Low Doses on Hormone-Sensitive Cells
por: Yue, Wei, et al.
Publicado: (2019)

Estetrol Cotreatment of Androgen Deprivation Therapy in Infiltrating or Metastatic, Castration-sensitive Prostate Cancer: A Randomized, Double-blind, Phase II Trial (PCombi)
por: Coelingh Bennink, Herjan J.T., et al.
Publicado: (2021)

Estetrol: A New Choice for Contraception
por: Fruzzetti, Franca, et al.
Publicado: (2021)

Estetrol‐Drospirenone combination oral contraceptive: a clinical study of contraceptive efficacy, bleeding pattern and safety in Europe and Russia
por: Gemzell‐Danielsson, K, et al.
Publicado: (2021)

Estetrol/Drospirenone: A Review in Oral Contraception
por: Lee, Arnold, et al.
Publicado: (2022)

Estetrol: From Preclinical to Clinical Pharmacology and Advances in the Understanding of the Molecular Mechanism of Action
por: Gérard, Céline, et al.
Publicado: (2023)

Correction: Estetrol/Drospirenone: A Review in Oral Contraception
por: Lee, Arnold, et al.
Publicado: (2022)

RF34 | PMON202 The Human Metabolic Profile of Estetrol
por: Gérard, Céline, et al.
Publicado: (2022)

Testosterone suppression combined with high dose estrogen as potential treatment of SARS-CoV-2. A mini review
por: Coelingh Bennink, Herjan J.T., et al.
Publicado: (2022)

Estrogen receptors and estetrol-dependent neuroprotective actions: a pilot study
por: Tskitishvili, Ekaterine, et al.
Publicado: (2016)

Target expression is a relevant factor in synthetic lethal screens
por: Schultz, Iman J., et al.
Publicado: (2022)

SUN-LB001 Estetrol (E4) Is a Unique Estrogen with Selective Actions in Tissues Which Are Distinctly Different from the Actions of SERMs
por: Foidart, Jean-Michel, et al.
Publicado: (2019)

Use of estetrol with other steroids for attenuation of neonatal hypoxic-Ischemic brain injury: to combine or not to combine?
por: Tskitishvili, Ekaterine, et al.
Publicado: (2016)

Comparison of Estetrol Exposure between Women and Mice to Model Preclinical Experiments and Anticipate Human Treatment
por: Gallez, Anne, et al.
Publicado: (2023)

Estetrol Is Safe and Well Tolerated during Treatment of Hospitalized Men and Women with Moderate COVID-19 in a Randomized, Double-Blind Study
por: Foidart, Jean Michel, et al.
Publicado: (2023)

The effect of combined oral contraception on testosterone levels in healthy women: a systematic review and meta-analysis
por: Zimmerman, Y., et al.
Publicado: (2014)

Combined estrogenic and anti-estrogenic properties of estetrol on breast cancer may provide a safe therapeutic window for the treatment of menopausal symptoms
por: Gérard, Céline, et al.
Publicado: (2015)

Pharmacology and Molecular Mechanisms of Clinically Relevant Estrogen Estetrol and Estrogen Mimic BMI-135 for the Treatment of Endocrine-Resistant Breast Cancer
por: Abderrahman, Balkees, et al.
Publicado: (2020)

Estetrol Modulates Endothelial Nitric Oxide Synthesis in Human Endothelial Cells
por: Montt-Guevara, Maria Magdalena, et al.
Publicado: (2015)

The uterine and vascular actions of estetrol delineate a distinctive profile of estrogen receptor α modulation, uncoupling nuclear and membrane activation
por: Abot, Anne, et al.
Publicado: (2014)

Maintaining bone health by estrogen therapy in patients with advanced prostate cancer: a narrative review
por: Coelingh Bennink, Herjan J T, et al.
Publicado: (2022)

Bleeding Patterns of Oral Contraceptives with a Cyclic Dosing Regimen: An Overview
por: Archer, David F., et al.
Publicado: (2022)

Contraceptive efficacy and tolerability of ethinylestradiol 20 µg/drospirenone 3 mg in a flexible extended regimen: an open-label, multicentre, randomised, controlled study
por: Klipping, Christine, et al.
Publicado: (2012)

Effects of Estetrol on Migration and Invasion in T47-D Breast Cancer Cells through the Actin Cytoskeleton
por: Giretti, Maria Silvia, et al.
Publicado: (2014)

No Interacting Influence of Lavender Oil Preparation Silexan on Oral Contraception Using an Ethinyl Estradiol/Levonorgestrel Combination
por: Heger-Mahn, Doris, et al.
Publicado: (2014)

Hemostatic Effects of a Novel Estradiol-Based Oral Contraceptive: An Open-Label, Randomized, Crossover Study of Estradiol Valerate/Dienogest versus Ethinylestradiol/Levonorgestrel
por: Klipping, Christine, et al.
Publicado: (2012)

Estetrol Increases Progesterone Genetic Response without Triggering Common Estrogenic Effects in Endometriotic Cell Lines and Primary Cultures
por: Patiño-García, Daniel, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_2bniamnsvierq44j11aeehoqvg